<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02203656</url>
  </required_header>
  <id_info>
    <org_study_id>13-038</org_study_id>
    <secondary_id>1229</secondary_id>
    <nct_id>NCT02203656</nct_id>
  </id_info>
  <brief_title>Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults</brief_title>
  <acronym>PACE</acronym>
  <official_title>Feasibility Study of Post-hospitalization Interventions to Improve Physical Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Medical Branch, Galveston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dairy Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Dairy Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Medical Branch, Galveston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the feasibility of interventions to accelerate recovery
      of muscle mass and function in older adults following acute hospitalization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to test the feasibility of interventions to accelerate recovery
      of muscle mass and function in older adults following acute hospitalization
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2013</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Short Physical Performance Battery- Gait, Balance, Chair Rise changes in functional measure score</measure>
    <time_frame>at pre-testing, 1-week post discharge and 4-week post discharge</time_frame>
    <description>Changes in SPPB score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Composition</measure>
    <time_frame>at pre-testing, 1-week post discharge and 4-week post discharge</time_frame>
    <description>Body composition will be measured using a bioimpedance scale. Changes in weight and % body fat will be calculated over the duration of the intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hand grip strength (kg)</measure>
    <time_frame>at pre-testing, 1-week post discharge and 4-week post discharge</time_frame>
    <description>Changes in hand grip will be calculated over duration of study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ADLS, IADLS</measure>
    <time_frame>at pre-testing, 1-week post discharge and 4-week post discharge</time_frame>
    <description>Changes in Instrumental activities of daily living (IADLS), and Activities of daily living (ADLS) will be measured over the duration of the intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity Levels</measure>
    <time_frame>at pre-testing, 1-week post discharge and 4-week post discharge</time_frame>
    <description>Physical activity levels will be measured using a step activity monitor and actiwatch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait Speed (m/s)</measure>
    <time_frame>at pre-testing, 1-week post discharge and 4-week post discharge</time_frame>
    <description>Changes in gait speed will be calculated over duration of study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Measures</measure>
    <time_frame>at pre-testing, 1-week post discharge and 4-week post discharge</time_frame>
    <description>microRNA levels in blood will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 day re-hospitalization</measure>
    <time_frame>30 days post-discharge</time_frame>
    <description>re-hospitalization rates will be collected</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Follow-up Measures</measure>
    <time_frame>1 year post discharge</time_frame>
    <description>Rehospitalization: date of rehospitalization, duration, and discharge diagnosis Death: date of death</description>
  </other_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">113</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Placebo Supplement</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Daily placebo supplement for 30 days after discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nutritional Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily nutritional supplement for 30 days after discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>In-home exercise + placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>in-home exercise 3 times a week and daily placebo supplement for 30 days after discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>In-home exercise + nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>in-home exercise 3 times a week and daily nutritional supplement for 30 days after discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Testosterone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single testosterone injection within 24 hours of hospital discharge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo supplement</description>
    <arm_group_label>Placebo Supplement</arm_group_label>
    <arm_group_label>In-home exercise + placebo</arm_group_label>
    <other_name>Control</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nutritional Supplement</intervention_name>
    <description>protein supplement</description>
    <arm_group_label>Nutritional Supplement</arm_group_label>
    <arm_group_label>In-home exercise + nutrition</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>In-home exercise</intervention_name>
    <description>In-home exercise program</description>
    <arm_group_label>In-home exercise + placebo</arm_group_label>
    <arm_group_label>In-home exercise + nutrition</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Testosterone</intervention_name>
    <description>Testosterone injection</description>
    <arm_group_label>Testosterone</arm_group_label>
    <other_name>Testosterone enanthate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted to the University of Texas Medical Branch (UTMB) ACE unit with an admitting
             diagnosis of congestive heart failure, respiratory infection, kidney/urinary tract
             infection, or metabolic disorder; or other condition that will allow a subject to
             participate in the study after patient review

          -  Aged 65 years or older

          -  Self-reported ability (with or without the aid of an assistive device) to walk across
             a small room two weeks prior to hospitalization

          -  Lives within 30 miles of UTMB

          -  Can stand without assistance at the time of pretesting

          -  Presents no medical contraindication to wearing a loose fitting velcro strap for the
             accelerometer on one ankle

          -  Score â‰¥26 on the 30-item Mini Mental State Examination or alert and oriented X3 by
             physician on H&amp;P

          -  Is discharged &quot;to home&quot; at ACE unit discharge.

        Exclusion Criteria:

          -  Nursing home resident or hospice patient

          -  Uncontrolled blood pressure (systolic &gt;150, or diastolic &gt; 100)

          -  History of stroke with motor disability

          -  Glomerular filtration rate (GFR) &lt;30 mL/min/1.73m2 or evidence of kidney disease or
             failure

          -  Liver disease ( aspartate aminotransferase (AST) /Alanine transaminase (ALT) 2 times
             above the normal limit, hyperbilirubinemia)

          -  Recent (within 3 months) treatment with anabolic steroids

          -  Any other condition or event considered exclusionary by the PI and faculty physician

          -  Planned or elective hospitalization within 30 days of discharge

        Additional Exclusion Criteria for Subjects Randomized to the Testosterone Group

          -  Breast or prostate cancer

          -  Palpable prostate nodule or induration or prostate specific antigen (PSA) â‰¥ 4 ng/ml

          -  PSA â‰¥ 3 ng/ml in men at high risk of prostate cancer, such as African Americans or men
             with first-degree relatives with prostate cancer

          -  Hematocrit â‰¥ 50%

          -  Decompensated heart failure as determined by a physician
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena Volpi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UTMB</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UTMB Acute Care for Elders Unit</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77550</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jennie Sealy Hospital</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Deer RR, Dickinson JM, Fisher SR, Ju H, Volpi E. Identifying effective and feasible interventions to accelerate functional recovery from hospitalization in older adults: A randomized controlled pilot trial. Contemp Clin Trials. 2016 Jul;49:6-14. doi: 10.1016/j.cct.2016.05.001. Epub 2016 May 10.</citation>
    <PMID>27178766</PMID>
  </reference>
  <results_reference>
    <citation>Deer RR, Goodlett SM, Fisher SR, Baillargeon J, Dickinson JM, Raji M, Volpi E. A Randomized Controlled Pilot Trial of Interventions to Improve Functional Recovery After Hospitalization in Older Adults: Feasibility and Adherence. J Gerontol A Biol Sci Med Sci. 2018 Jan 16;73(2):187-193. doi: 10.1093/gerona/glx111.</citation>
    <PMID>28591764</PMID>
  </results_reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2014</study_first_submitted>
  <study_first_submitted_qc>July 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2014</study_first_posted>
  <last_update_submitted>December 21, 2017</last_update_submitted>
  <last_update_submitted_qc>December 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intervention studies</keyword>
  <keyword>nutrition</keyword>
  <keyword>exercise</keyword>
  <keyword>testosterone</keyword>
  <keyword>patient readmission</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Testosterone enanthate</mesh_term>
    <mesh_term>Testosterone undecanoate</mesh_term>
    <mesh_term>Testosterone 17 beta-cypionate</mesh_term>
    <mesh_term>Methyltestosterone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No. This is a small Phase 1 pre-pilot study. Risk of loss of confidentiality</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

